An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Amy Zhang, PhD
Kyowa Hakko Kirin Pharma, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
6 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Shriners Hospital for Children - Canada
Montreal, Quebec, Canada
- University of California San Francisco
San Francisco, California, United States
- Yale University School of Medicine
New Haven, Connecticut, United States
- Clinical Research Center, Indiana University School of Medicine
Indianapolis, Indiana, United States
- Duke Clinical Research Unit
Durham, North Carolina, United States
- University of Texas Health Science Center at Houston
Houston, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 29 Feb 2012
- Primary completion
- 30 Sept 2013
- Completion
- 30 Jun 2014
- Last update posted
- 18 Jun 2024
- Registered enrollment
- 23
- Registry id
- NCT01571596
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.